About: Preventing airborne infection with an intranasal cellulose powder formulation (Nasaleze Travel®)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Preventing airborne infection with an intranasal cellulose powder formulation (Nasaleze Travel®) Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Preventing airborne infection with an intranasal cellulose powder formulation (Nasaleze Travel®)
Creator	Hiltunen, Raimo James, Mike Josling, P Josling, Peter
Source	Medline; PMC
abstract	A total of 52 volunteers were recruited to take part in a dual-centered, randomized, blinded study so investigators could determine whether the level of airborne infection could be significantly reduced in patients randomly assigned to treatment with either Nasaleze® cellulose extract alone or a combination of Nasaleze cellulose and powdered garlic extract (PGE). One puff into each nostril was recommended, and volunteers who developed an infection while traveling were told to use at least 3 puffs per nostril until symptoms were reduced. This study took place over an 8-wk period across Finland and the United Kingdom between November 2006 and March 2007. Volunteers were instructed to use a 5-point scale to assess their health and to record infectious episodes and symptoms in a daily diary. The activetreatment group (Nasaleze cellulose with PCE) experienced significantly fewer infections than the control group (20 vs 57; P<.001) and far fewer days on which an infection was obviously present (126 d in the active group vs 240 d in the control group; P<.05). Consequently, volunteers in the active group were less likely to pick up an airborne infection when PCE was added to this novel cellulose extract. Volunteers in the control group were much more likely to report more than 1 infectious episode over the treatment period or to endure longer periods of infection. The investigators concluded that the combination Nasaleze Travel formulation significantly reduced the number of airborne infections to which volunteers were exposed while traveling.
has issue date	2007-01-01(xsd:dateTime)
bibo:doi	10.1007/bf02877720
bibo:pmid	18029341
has license	no-cc
sha1sum (hex)	ead15e3d5220896a114a9e158ea54358273591f6
schema:url	https://doi.org/10.1007/bf02877720
resource representing a document's title	Preventing airborne infection with an intranasal cellulose powder formulation (Nasaleze Travel®)
has PubMed Central identifier	PMC7091244
has PubMed identifier	18029341
schema:publication	Adv Ther
resource representing a document's body	covid:ead15e3d5220896a114a9e158ea54358273591f6#body_text
is schema:about of	named entity 'number' named entity 'Travel' named entity 'diary' named entity 'Formulation' named entity 'Intranasal' named entity 'Airborne' named entity 'MARCH' named entity 'AIRBORNE' named entity 'CENTERED' named entity 'ACTIVE' named entity 'EXPERIENCED' named entity 'REPORT' named entity 'NOVEL' named entity 'CONTROL GROUP' named entity 'PUFFS' named entity 'MORE THAN' named entity '28126' named entity 'NOSTRIL' named entity 'TRAVELING' named entity 'FORMULATION' named entity 'INFECTION' named entity 'COULD BE' named entity 'DAILY' named entity 'TRAVEL' named entity 'PGE' named entity '240' named entity 'THEIR' named entity 'airborne' named entity 'record' named entity 'period' named entity 'cellulose' named entity 'blinded study' named entity 'infections' named entity 'Volunteers' named entity 'airborne' named entity 'November' named entity 'volunteers' named entity 'combination' named entity 'infection' named entity 'cellulose' named entity 'infection' named entity 'nostril' named entity 'infection' named entity 'nostril' named entity 'randomly assigned' named entity 'Intranasal' named entity 'London' named entity 'airborne infections' named entity 'infection' named entity 'infection' named entity 'garlic cloves' named entity 'infection' named entity 'natural remedies' named entity 'directly related' named entity 'cold germs' named entity 'colds' named entity 'common cold viruses' named entity 'sample variance' named entity 'young children' named entity 'colds' named entity 'antiviral activity' named entity 'parainfluenza' named entity 'infection' named entity 'airborne infections' named entity 'common cold' named entity 'coronaviruses' named entity 'infection' named entity 'airborne infections' named entity 'Cellulose' named entity 'viruses' named entity 'cellulose' named entity 'blinded study' named entity 'respiratory syncytial virus' named entity 'control group' named entity 'cellulose' named entity 'infection' named entity 'garlic' named entity 'human cytomegalovirus'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software